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license (http://creativecommons.org/Summary Objective: The objective of this study was to define the nasal microbiome of hos-
pital inpatients who are persistently colonized with methicillin-resistant Staphylococcus
aureus (MRSA) compared with matched, non-colonized controls.
Methods: Twenty-six persistently MRSA-colonized subjects and 26 matched non-colonized con-
trols were selected from the screening records of the infection control program at the Depart-
ment of the Veteran Affairs Eastern Colorado Health Care System (VA-ECHCS). The nasal
microbiotas were analyzed with PCR amplification and sequencing of the 16S ribosomal RNA
(rRNA) gene. Comparison of all variables across the groups was performed using stratified lo-
gistic regression to account for the one-to-one matching. Canonical discriminant analysis
was performed to assess differences in bacterial community across the two groups. Competing
organisms were cocultured with MRSA in vitro.
Results: There was a negative association between MRSA colonization and colonization with
Streptococcus spp. At the species level, multivariate analysis demonstrated a statistically sig-
nificant negative association between colonization with Streptococcus mitis or Lactobacillus
gasseri and MRSA. Coculture experiments revealed in vitro competition between S. mitisiseases (111L), 1055 Clermont Street, Denver, CO 80220, USA. Tel.: þ1 303 393 2837; fax: þ1 303 393
denver.edu (M.T. Bessesen).
.08.008
n behalf of The British Infection Association. This is an open access article under the CC BY-NC-ND
licenses/by-nc-nd/4.0/).
650 M.T. Bessesen et al.and all of the 22 MRSA strains isolated from subjects. Competition was blocked by addition of
catalase to the media. Persistently colonized subjects had lesser microbial diversity than the
non-colonized controls.
Conclusion: In a high-risk inpatient setting, bacterial competition in the nasal niche protects
some patients from MRSA colonization.
Published by Elsevier Ltd on behalf of The British Infection Association. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Staphylococcus aureus is a common pathogen that has hin-
dered attempts at effective control by immunization1 or
antibacterial therapy. The majority of clinical isolates of
S. aureus in the United States are methicillin resistant.2
S. aureus is the most common pathogen in surgical site in-
fections and the second most common cause of hospital-
associated bacteremia,3 causing extended hospital stays
and increased health-care costs.4 The attributable mortal-
ity of S. aureus bloodstream infection is 19% for
methicillin-sensitive strains and 33% for methicillin-
resistant S. aureus (MRSA).4 The high costs of S. aureus
infection in terms of dollars, morbidity, and mortality de-
mand the development of new effective methods to control
this pathogen.
Nasal colonization is a potent risk factor for S. aureus
infection. Colonization of the nares is associated with a
three- to 13-fold increased risk of S. aureus infection.5,6 A
study of nosocomial S. aureus bacteremia demonstrated
nasal colonization on admission in the majority of cases.6
In 80% of these S. aureus bacteremia cases, the infecting
strain was identical to the colonizing strain recovered prior
to infection,7 confirming that nasal colonization is the pre-
decessor to infection. Decolonization therapy reduces the
risk of health-care-associated S. aureus infection in high-
risk settings such as surgery or critical care,8,9 supporting
the hypothesis that colonization leads to infection.
The duration of S. aureus colonization and burden of or-
ganisms varies among individuals. A commonly used defini-
tion of persistent colonization is two positive nasal cultures
1 week apart10; a more rigorous definition is positive nasal
cultures on 80% of 5 samples obtained at least 1 week
apart.11 Risk factors for persistent colonization include dia-
betes mellitus, dialysis-dependent kidney failure, and HIV
infection. However, these factors alone do not explain
why many people are persistently colonized, while the ma-
jority of humans are not.7
We hypothesized that colonization and invasion by MRSA
may be inhibited by the resident microbiota of the nasal
niche. A previous study of hospitalized patients by our
group demonstrated a negative association between S.
aureus colonization and Staphylococcus epidermidis coloni-
zation of the anterior nares, a site that is characterized by
stratified epithelium.12 Iwase et al. found no difference be-
tween S. aureus carriers and noncarriers in colonization
with S. epidermidis. When they investigated individual
strains of S. epidermidis, they found that strains that pro-
duce the serine protease Esp were negatively associated
with S. aureus colonization.13 Detailed studies of the micro-
biota at three sites within the nasal cavity of six healthy S.
aureus carriers and six noncarriers demonstrated a negativeassociation between Corynebacterium pseudodiphthericum
and S. aureus colonization at the middle meatus and sphe-
noethmoidal recess, but not in the anterior nares.14 Simi-
larly, Wos-Oxley also found an inverse correlation
between C. pseudodiphthericum and Finegoldia magna
with S. aureus in healthy volunteers.15 In contrast to these
results in healthy young adults, our group has focused on
hospitalized adults, who bear the greatest burden of S.
aureus infection. Our previous study12 analyzed surveil-
lance swabs collected at admission, without distinguishing
among persistently, transiently, and never colonized indi-
viduals. Consequently, to more precisely define the micro-
bial correlates of MRSA carriage, we performed a controlled
study of the microbiota associated with persistent MRSA
colonization compared with that in matched subjects who
remained non-colonized. We chose to study a population
of hospitalized patients, because of the heavy exposure
to MRSA, the high risk of symptomatic infection, and the
substantial mortality associated with MRSA infections in
this population.Methods
Study design
The study was conducted at the Department of Veterans
Affairs Eastern Colorado Health Care System (VA-ECHS), a
tertiary-care medical center with 137 beds and 5000
admissions per year, which provides care to veterans drawn
from a service area that includes Colorado, Wyoming,
Montana, and parts of New Mexico. Samples obtained
during the conduct of an active MRSA screening and
isolation program were used for the study. Patients were
screened for MRSA colonization with both heads of a paired
nasal swab rotated in the distal nares bilaterally at
admission, inter-ward transfer, weekly intervals of a 7-
day stay in a ward, discharge, and death. The clinical
laboratory used one swab to perform real-time PCR of
admission swabs using the Infinity MRSA assay (Cepheid,
Sunnyvale, CA) according to the manufacturer’s instruc-
tions, to identify MRSA colonization on admission. Selective
MRSA agar plates were used to test nasal swabs obtained at
other time points. The second swab of the pairs collected
during the sample collection period, 7/1/2012e6/30/2013,
was stored in a sterile, molecular biology-grade micro-
centrifuge tube at 80 C. Results of all screening tests
performed in the clinical microbiology laboratory from 1
March 2007 to 30 June 2013 were reviewed, and subjects
who met the case definitions were selected. The most
recent swab in the collection, representing the longest
period of colonization, was selected for study. MRSA
Nasal microbiome and MRSA colonization 651isolates were collected and stored for all colonized cases
that were identified by culture.
Ethics declaration
The study was approved by the Colorado Multiple Institu-
tional Review Board, protocol #12-0346. Informed consent
was not sought for the use of discarded samples.
Definitions
An MRSA persistent carrier case was defined as a subject
from whom 5 swabs have been taken, at least 1 week
apart, and 80% of nasal swab specimens, including the
final specimen, were positive for MRSA. An MRSA noncarrier
control was defined as a subject from whom 5 swabs were
collected, at least 1 week apart, and all swabs were
negative for MRSA.
Matching
Noncarrier controls were matched to persistent carrier
cases for known colonization risk factors, including age
(10 years), gender, race, long-term care residence,
diabetes mellitus, HIV infection, end-stage renal disease,
nasal glucocorticoid use, and antibacterial therapy in the 4
weeks prior to sampling. The electronic medical record was
reviewed for clinical data. Cases and controls were
excluded if they had an upper respiratory infection at the
time of sample acquisition, or if they were treated with
mupirocin or rifampin in the year prior to screening.
High-throughput DNA sequencing for microbiome
analysis
DNA extraction
Microbial cells were lysed by the addition of 300 mL of
10 mM Tris, 0.1 mM ethylenediaminetetraacetic acid
(EDTA), and 300 mL of 1% NP40 directly to the swab storage
microfuge tube. The tubes were heated for 10 min at 95 C
followed by bead beating at 5500 rpm for 30 s in a bead
beater (Roche, San Francisco, CA, USA). Microfuge tubes
were centrifuged at 8000  g for 1 min. DNA was purified
from the supernatant using a Zymo DNA Clean and Concen-
trator Column according to the manufacturer’s instructions
(Zymo, Irvine, CA, USA).
Sequencing
16S Amplicon Library Construction. Bacterial profiles were
determined by broad-range amplification and sequence
analysis of 16S ribosomal RNA (rRNA) genes following our
previously described methods.16,17 In brief, amplicons were
generated using primers 27FYM (50 AGAGTTTGATYMTGGCT-
CAG)18 and 338R (50 TGCTGCCTCCCGTAGGAGT),19 which
target approximately 300 base pairs of the V1V2 variable
region of the 16S rRNA gene; primers were modified by
addition of Illumina P7 and P5 adapter sequences along
with six-nucleotide (nt) index sequences. PCR products
were normalized using a SequalPrep kit (Invitrogen, Carls-
bad, CA, USA), pooled, lyophilized, purified, and concen-
trated using a DNA Clean and Concentrator Kit (Zymo,Irvine, CA, USA). Pooled amplicons were quantified using
a Qubit Fluorometer 2.0 (Invitrogen, Carlsbad, CA, USA).
The pool was diluted to 4 nM and denatured with 0.2 N
NaOH at room temperature. The denatured DNA was
diluted to 15 pM and spiked with 25% of the Illumina PhiX
control DNA before loading the sequencer. Illumina
paired-end sequencing was performed on the Miseq plat-
form with version v2.3.0.8 of the Miseq Control Software
and version v2.3.32 of MiSeq Reporter, using a 600-cycle
version 3 reagent kit.
Analysis of Illumina paired-end reads
Illumina Miseq paired-end sequences were sorted by sample
via barcodes in the paired reads with a python script.17,20
Sorted paired-end sequence data were deposited in the
NCBI Short Read Archive under accession number
PRJNA280776. Assembled sequences were aligned and clas-
sified with SINA (1.2.11)21 using 418,497 bacterial se-
quences in Silva 115NR9922 as reference configured to
yield the Silva taxonomy. Species-level taxonomic precision
was obtained via BLAST23 of subject sequences against a
database built from Silva22 bacterial sequences marked as
type strains, cultivars, or genomes. Species names were as-
signed when subject sequences overlapped Silva sequences
by at least 95% with 99% sequence identity and the taxon-
omy of the database hit matched the taxonomy returned
by SINA.21 Operational taxonomic units (OTUs) were pro-
duced by clustering sequences with identical taxonomic as-
signments. This process generated 4,689,903 sequences for
52 samples (average sample size: 90,190 sequences/sam-
ple; minimum: 5218 sequences; maximum: 184,664 se-
quences). The software package Explicet (v2.9.4, www.
explicet.org)24 was used for display, analysis, and figure
generation of results.
In vitro competition experiments
The Streptococcus mitis ATCC strain 49456 was purchased
from American Type Tissue Collection. Streptococcus angi-
nosus and the Enterococcus spp. strains 1b and 2a were
clinical isolates; they were identified by standard pheno-
typic methods. Streptococcus pneumoniae was donated
by Ed Janoff. Cultures were grown overnight in 5 mL of
braineheart infusion (BHI) medium at 37 C. S. mitis, S. an-
ginosus, and S. pneumoniae were grown statically in a 5%
CO2 incubator. S. aureus and Enterococcus spp. were grown
by shaking at 180 rpm. After overnight growth, 1  104 S.
aureus cells were plated on trypticase soy agar (TSA) and
left to dry for 10 min. Next, 10 mL of the challenge strains
were spotted on the S. aureus-inoculated TSA plates.
Enterococcus 1b was diluted fivefold in BHI medium before
spotting. All spots were left to dry 10 min, and then the
plates were incubated overnight at 37 C in a 5% CO2
incubator.
Statistical analysis
To account for differences in sequencing depth, the
relative abundance (RA) of each taxa was calculated
(number of sequences for specific taxa/total number of
Table 1 Patient demographics.
Control
N Z 26
Case
N Z 26
Age, mean (std) 71.8 (11.2) 71.7 (11.4)
Male 26 (100%) 26 (100%)
Antibiotics 15 (58%) 15 (58%)
Diabetes 13 (50%) 13 (50%)
Nasal steroids 3 (12%) 3 (12%)
Nursing home 5 (19%) 5 (19%)
Smoking status
Never 7 (27%) 9 (35%)
Former 9 (35%) 13 (50%)
Current 10 (38%) 4 (15%)
652 M.T. Bessesen et al.sequences  100). Common ecological measures (Shannon
diversity and evenness) were calculated using rarefaction
to 1000 sequences in Explicet.21 Shannon diversity was con-
verted to effective number of taxa for interpretation.25 A
small constant (1/total) was added to the counts to elimi-
nate zeros prior to the application of the centered log-
ratio transformation recommended for multivariate anal-
ysis of compositional data.26,27 Canonical discriminant anal-
ysis was performed to assess multivariate differences in
bacterial community between the two groups. Common
ecological measures (Shannon diversity and evenness)
were calculated using rarefaction to 1000 sequences in Ex-
plicet.24 The Shannon diversity index was converted to the
effective number of taxa for interpretation.25 Comparison
of all variables (diversity and individual taxa) across the
groups was performed using stratified logistic regression
to account for the one-to-one matching. Communities
across sample types within a subject were compared using
Shannon beta, a measure of b-diversity.28 This approach ex-
tends the b-diversity measure to apply to a group of sam-
ples rather than just for pair-wise comparisons. For ease
of clinical interpretation, Shannon beta is expressed as a
Hill number, which indicates the effective number of com-
munities represented by the group of samples. Comparison
of all variables (diversity and individual taxa) across the
groups was performed using stratified logistic regression
to account for the one-to-one matching. All statistical ana-
lyses were performed using SAS version 9.3 software (SAS
Institute Inc.: Cary, NC, USA, 2011).
Results
Study population
A total of 28,627 nasal swab samples were obtained at
admission from 29,140 patients (98.2% screening rate)
between 1 March 2007 and 30 June 2013, and tested for
MRSA in the clinical microbiology laboratory. Among these
28,627 swabs, 3164 were positive for MRSA (11.1% preva-
lence). The incidence of MRSA transmission during the study
period was 1.55/1000 patient days. A total of 39 patients
met the definition of MRSA persistent carrier and provided a
sample during the sample collection period, 7/1/2012 and
6/30/2013. One patient was excluded because he had
influenza on the sample collection date and another was
excluded because he was enrolled in a competing study. A
matched control was not available for five patients. A total
of six case samples failed to amplify in the PCR. The
remaining 26 cases were paired with 26 matched controls.
The details of the cases and controls are given in Table 1.
An average of 11.7  6.4 swabs were collected from
MRSA-colonized subjects and tested in the clinical microbi-
ology laboratory over an average of 140  83 weeks, and
11.8  5.6 swabs over 150  85 weeks from non-colonized
controls (P Z 0.97). The mean age of the subject popula-
tion was 71.7  11.2 years; 50% had diabetes mellitus,
19% were nursing home residents, 12% had been exposed
to nasal steroids in the previous 6 months, and 58% had
been exposed to antibacterial agents in the previous
month. An MRSA isolate was available for 22 of the 26
persistently colonized patients.Microbial communities
Bacteria sampled by anterior nare swabbing were identified
by sequencing the 16S rRNA V1V2 region, which was chosen
based on its ability to discriminate S. aureus from S. epider-
midis.12,29 16S rRNA sequencing was successful, and deep
sequence coverage was attained for all samples. As in our
previous surveillance of hospitalized patients, as well as
studies of healthy individuals, nasal microbiotas were char-
acterized by diverse members of the phyla Actinobacteria
(e.g., Corynebacterium spp. and Propionibacterium spp.)
and Firmicutes12,14,30 (Fig. 1). Among the study subjects,
S. aureus 16S rRNA sequences were detected in all MRSA
cases and five of 26 MRSA negative controls; the sequences
detected in controls presumably were indicative of coloni-
zation by methicillin-sensitive S. aureus strains. The me-
dian abundance of S. aureus was 31.8% of sequences in
MRSA-colonized cases (interquartile range: 1.5e69.4%)
and 0.03% in controls (interquartile range: 0.01e0.31%).
Canonical discriminant analysis was performed to identify
differences in bacterial communities between MRSA-
colonized subjects and non-colonized controls, after first
excluding S. aureus sequences from thedataset. This analysis
demonstrated a clear separation between the nasal micro-
biota of MRSA-colonized cases and non-colonized controls
(Fig. 2). The majority of the separation was due to the first
canonical component. The organisms with the most signifi-
cant negative and positive association with MRSA coloniza-
tion are displayed in Fig. 3. Stratified logistic regression
analysis demonstrated a statistically significant negative as-
sociation between colonization with MRSA and streptococci
at the genus level. At the species level, S. mitis was signifi-
cantlymore common inMRSAnon-colonized control subjects.
To explore the impact of antibiotics on this observation, the
analyses were repeated in subgroups of patients and controls
who had been exposed to antibiotics in themonth prior to en-
try and in thosewithout antibiotic exposure. The negative as-
sociation between MRSA and S. mitis persisted in both
subgroups with and without antibiotic exposure.Bacterial diversity
As measured by the Shannon diversity index, the bacterial
communities of non-colonized controls were 2.2 times more
MRSA Colonized Cases Controls
Actinomyces spp.
Corynebacterium spp.
Coryne. fastidiosum
Coryne. kroppenstedtii
Coryne. propinquum
Coryne. pseudodiphtheriticum
Coryne. segmentosum
Coryne. striatum
Coryne. tuberculostearicum
Gordonia spp.
Propionibacterium spp.
Propionibacterium acnes
Propion. granulosum
Staphylococcus spp.
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus hominis
Staphylococcus lugdunensis
Staph. pseudointermedius
Streptococcus mitis
Anaerococcus spp.
Peptoniphilus spp.
Caulobacter spp.
Neisseria spp.
Uruburuella spp.
Moraxella catarrhalis
Moraxella nonliquefaciens
Stenotrophomonas maltophila
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Figure 1 Heat map comparing the relative abundances of species-level OTUs across groups. Color coding denotes the percentage
of relative abundances of OTUs within each subject. Individual subjects are designated by tick marks along the top x-axis. Species
are categorized by phylum (Proteo Z Proteobacterium).
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tive number of taxa of 30 (Shannon Index Z 3.4) and 13.5
(Shannon Index Z 2.6), respectively; P Z 0.01). Further-
more, MRSA-colonized subjects were characterized by
more uneven bacterial communities than those observed
among the non-colonized controls, corresponding to theDolosigranulum spp.
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S. mitis
Streptococcus spp.
Peptoniphilus spp. C. fastidiosum C. striatum
C. amycolatum
S. pyogenes
P. mirabilis
Microvirgula spp.
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Figure 2 Canonical discriminant analysis of the nasal micro-
biomes of MRSA-colonized cases versus non-colonized controls
after removing S. aureus. The biplot designates the most influ-
ential species in separating cases from controls multivariately.concept that nasal communities in colonized subjects
have dominant organisms (Fig. 4). Shannon b-diversity, a
measure of the difference in communities across samples
within each group, was lower in MRSA-colonized subjects
than in controls. Hill numbers for b-diversity, which pro-
vides an estimate of the number of distinct communities
across samples within a group, suggest that the samples
from the MRSA-colonized subjects are more similar to
each other than the samples in the non-colonized group
(2.9 distinct communities vs. 3.6 distinct communities,
respectively).In vitro competition experiments
The results of the 16S rRNA sequence analysis implicated
several species, most notably S. mitis, in the dynamics of
MRSA colonization. The cross-sectional study design does
not, however, indicate whether these species interfere
with, or are simply displaced by, S. aureus colonization.
Consequently, we performed in vitro coculture plating as-
says in which the growth of multiple MRSA isolates was chal-
lenged with S. mitis and related species. When performed
on TSA, S. mitis inhibited the growth of all 22 MRSA isolates
tested. Representative experiments are displayed in Fig. 5.
Addition of w200 U/ml of catalase, which inactivates
hydrogen peroxide, to the media blocked this inhibition.
The S. mitis results are similar to the inhibition of S. aureus
growth with S. pneumoniae, a prominent producer of H2O2.
0.5 1 1.5 2 2.5 3 3.5 4.5
Streptococcus spp.
Staphylococcus pseudintermedius
Streptococcus mitis
Finegoldia spp.
Corynebacterium simulans
Peptoniphilus spp.
Streptococcus infantis
Lactobacillus gasseri
Catonella morbi
Kocuria palustris
Streptococcus mutans
Acinetobacter baumannii
Streptococcus vestibularis
Pedobacter spp.
Acinetobacter junii
Staphylococcus spp.
Staphylococcus aureus
Lower in MRSA Higher in MRSA
Odds Ratio and 95% CL
Figure 3 Forest plot displaying the top organisms, which individually discriminated between groups. Odds ratios and 95% confi-
dence intervals are presented; taxa are ordered according to the magnitude of the odds ratio.
654 M.T. Bessesen et al.By contrast, none of the other species in the Firmicutes
phylum tested (Enterococcus spp. isolates 1a and 2b and
S. anginosus) produced a zone of S. aureus inhibition.
Discussion
This study identified several organisms in the nasal micro-
bial communities of hospital inpatients who were associ-
ated with the absence of MRSA colonization despite
extensive exposure. The strongest negative associations
were found for S. mitis and Lactobacillus gasseri. Consis-
tent with these observations, S. mitis inhibited the growth
of each of the 22 MRSA isolates identified. The addition of
catalase to the media blocked this inhibition, suggesting
that the inhibition was due to hydrogen peroxide. However,
hydrogen peroxide from S. mitis may not be subject to the
equal impact of all bacteria, as the nasal microbiome was
less, rather than more, diverse in MRSA-colonized cases,
which largely lacked S. mitis, than in non-colonized con-
trols. These observations represent the largest analysis to
date of the role of the nasal microbiome in host defense
against MRSA colonization. Our finding of greater diversityS
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Figure 4 Diversity of bacterial species in the nasal niche. Panel A
left and a connecting line to the Shannon H value of the matched c
ness. Matched paired subjects are connected by a gray line; the min non-colonized subjects contrasts with our smaller, previ-
ous point prevalence study of the microbiome among MRSA-
colonized and non-colonized individuals.12 An earlier work
used a single sample to identify subjects as MRSA colonized
or free of colonization. The current work represents a pop-
ulation in which the definitions of persistent MRSA coloniza-
tion and non-colonization were more rigorous, selecting
only those subjects with extensive exposure to the inpa-
tient environment and persistent colonization on longitudi-
nal follow-up for an average of 140 weeks.
To our knowledge, the identification of S. mitis as a
competitor to MRSA is unique among culture-independent
studies of the anterior nasal microbiome. Previous reports,
which did not identify the negative association with S. mi-
tis, enrolled healthy volunteers to examine nasal coloniza-
tion with S. aureus.14,15 By contrast, we focused on older
hospitalized patients who suffer from both high rates and
morbid consequences of MRSA infections. A previous
culture-based study documented viridans group strepto-
cocci as competitors to MRSA in the oral cavity of newborns
in an intensive care unit.31 Thus, the role of streptococci
may be more prominent in an inpatient setting.Control
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Figure 5 Inhibition of MRSA growth by Streptococcus mitis. A lawn of MRSA was inoculated into each plate, and the competing
organisms were spotted on the plate in the indicated section. Panels A and B show coculture of two representative strains of MRSA
with S. mitis. Panels C and D show the same coculture experiments with the addition of catalase to the media.
Nasal microbiome and MRSA colonization 655Stratified logistic regression analysis also identified a
significantly decreased frequency of MRSA colonization
among subjects colonized with L. gasseri, as well as a trend
toward decreased MRSA colonization among subjects colo-
nized with Kocuria palustris. Both of these organisms
have been shown to inhibit S. aureus in vitro. K. palustris
produces kocurin, a thiazolyl peptide with activity against
MRSA.32 L. gasseri inhibits S. aureus in vitro via a hydrogen
peroxide mechanism.33 L. gasseri also activates macro-
phages in vitro and in a murine peritonitis model.34,35 The
identification of K. palustris and L. gasseri as constituents
of the human nasal microbiota is unique to this study.
Previous studies of the role of corynebacteria as com-
petitors to S. aureus in the nasal niche have produced con-
flicting results. Culture-based studies showed competition
between S. aureus and a single strain of Corynebacterium
spp., Co 304, and demonstrated eradication of S. aureus
carriage from the anterior nares by inoculation of humans
with Co 304.36 A culture-independent study of healthy vol-
unteers found inhibition of S. aureus by Corynebacterium
pseudodiphtheriticum, and enhancement of S. aureus by
Corynebacterium accolens. These interactions were identi-
fied only in deeper nasal sites and not in the anterior
nares.14 Consistent with the findings of Wos-Oxley
et al.,15 canonical analysis of our data showed that some
corynebacteria species were positively correlated with
MRSA colonization of the anterior nares, whereas other spe-
cies were negatively correlated. Multivariate analysisshowed only a trend toward a negative association between
colonization with MRSA and Corynebacterium simulans in
our population.
Our study builds on previous efforts to understand why
some humans are colonized with S. aureus, but others do
not. Data supporting the role of host genetics are few.
Genome-wide association studies of an isolated human pop-
ulation in the Amazon revealed an association between
single-nucleotide polymorphisms in the glucocorticoid re-
ceptor gene and S. aureus colonization.37 Although twin
studies have produced conflicting results,38,39 a recent,
carefully controlled twin study found that the concordance
rate for carriage did not differ significantly between mono-
zygotic and dizygotic twins.40 Colonization and infection
with MRSA probably reflect a complex interplay between
host genetics, exposure to the pathogen, immune function,
and the microbial occupants of the nasal niche.
Limitations of our study include the single-center design
and predominantly male population. We did not evaluate
the extranasal sites of colonization, which may limit the
generalizability of our results to some populations.
Community-acquired MRSA may be associated with extra-
nasal sites of colonization, with negative nare screens.41
However, a study of a population of hospitalized patients
similar to ours, using similar screening methods, demon-
strated that 98% of MRSA colonization was detected by
nasal screening.42 Therefore, in our population, nasal
screening should detect the overwhelming majority of
656 M.T. Bessesen et al.MRSA-colonized cases. The sequencing methods could not
distinguish methicillin-susceptible S. aureus (MSSA) from
MRSA. Thus, we were unable to assess the potential for
nasal MSSA to contribute to host defense against MRSA colo-
nization. Moreover, we had no access to data on the nasal
microbiome of subjects prior to MRSA colonization. Howev-
er, the ongoing work in our center focuses on microbial de-
terminants both before and after incident MRSA
colonization. The strengths of the study include the large
numbers of rigorously defined, persistently colonized cases,
and the well-matched, highly exposed controls that re-
mained MRSA negative on extensive screening. Study of
an inpatient population at a particularly high risk of MRSA
infection makes our results highly clinically relevant.
The identification of S. mitis as a competitor to S. aureus
in the nasal niche via a hydrogen peroxide mechanism indi-
cates that in an inpatient setting, with many complex fac-
tors affecting the microbial community, interspecies
competition may protect some hosts from highly virulent
pathogens. Furthermore, novel organisms with known
mechanisms of antistaphylococcal activity, L. gasseri and
K. palustris, were shown to be active against MRSA in the
nasal niche. S. mitis is closely related to S. pneumoniae,43
which also inhibits S. aureus colonization by an H2O2-medi-
ated mechanism.44 Although S. mitis carries many of the
same virulence genes as S. pneumoniae,43 and is a very
common colonizer of the human nares,30 it seldom causes
disease. Thus, S. mitis, L. gasseri, and K. palustris could
be investigated for use as probiotics. In summary, we stud-
ied hosts at a high risk of MRSA colonization and infection
and identified organisms that were potent inhibitors of
MRSA colonization. This proof of concept supports addi-
tional studies, which may lead to the development of pro-
biotic therapies or uncover microbial products with
therapeutic potential.
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